These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5994378)

  • 1. [Betaine aspartate in the hepato-digestive domain].
    Cachin M; Pergola F
    Sem Ther; 1966 Oct; 42(8):423-4. PubMed ID: 5994378
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic activity of betaine aspartate].
    Nicrosini F
    Clin Ter; 1972 May; 61(3):227-36. PubMed ID: 5050945
    [No Abstract]   [Full Text] [Related]  

  • 3. [Further clinical experiences with ornithine aspartate in liver diseases].
    Wotzka R; Weber D
    Ther Ggw; 1972 Mar; 111(3):400-12. PubMed ID: 5024593
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the therapy of liver diseases with ornithine aspartate].
    Melzer H; Weber D; Wotzka R
    Med Klin; 1969; 64(35):1541-4. PubMed ID: 5354488
    [No Abstract]   [Full Text] [Related]  

  • 5. [Betaine aspartate in the therapy of liver diseases].
    Cairella M; Volpari B
    Clin Ter; 1972 Mar; 60(6):513-34. PubMed ID: 5038777
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of treatment with nucleotides and aspartic acid in chronic liver diseases].
    Iencica R
    Med Interna (Bucur); 1972 Dec; 24(12):1449-53. PubMed ID: 4655566
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lipotropic effect of betaine aspartate on experimental hepatic steatosis. Study using triolein-C14].
    Perrault M; Dormard Y
    Therapie; 1966; 21(3):719-31. PubMed ID: 5942137
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experience with betain citrate (author's transl)].
    Babucke G; Sarre B
    Med Klin; 1973 Aug; 68(34):1109-13. PubMed ID: 4364431
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of liver diseases, especially of fatty liver with betaine citrate].
    Semmler F
    Ther Ggw; 1977 Nov; 116(11):2113-24. PubMed ID: 337559
    [No Abstract]   [Full Text] [Related]  

  • 10. [Value of an orotic acid-sorbitol combination in hepato-intestinal diseases. Point of view of a general practitioner].
    Lechat S; Pattin S; Vigne J
    Rev Corps Sante Armees Terre Mer Air; 1967 Apr; 8(2):259-66. PubMed ID: 4237949
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experiences with ornithine-aspartate in liver diseases].
    Aschke J
    Med Welt; 1969 Mar; 12():657-62. PubMed ID: 5767441
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical study on the effects of L-ornithine-L-aspartate on liver dysfunction].
    Kosozu K
    Iryo; 1966 Apr; 20(4):339-46. PubMed ID: 5974192
    [No Abstract]   [Full Text] [Related]  

  • 13. [A new biochemical aspect of liver therapy].
    Gäbler H
    Ther Ggw; 1971 Apr; 110(4):505-14. PubMed ID: 5574294
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of glucocorticoid therapy in liver diseases].
    Möller E; Brinkmann W; Weber O
    Med Welt; 1967 Apr; 14():884-9. PubMed ID: 5585085
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic trial with methylphenobarbital (Prominal), an enzyme inducer, in liver disease. A contribution to the question of hepatotoxicity of barbiturates.
    Glogner P; Massarrat S; Henrichs HR
    Acta Hepatosplenol; 1971; 18(5):394-7. PubMed ID: 5112056
    [No Abstract]   [Full Text] [Related]  

  • 16. Betaine: an old therapy for a new scourge.
    Neuschwander-Tetri BA
    Am J Gastroenterol; 2001 Sep; 96(9):2534-6. PubMed ID: 11569673
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical investigation of silymarin in chronic liver diseases (author's transl)].
    Realini S; Gonvers JJ; Hofstetter JR
    Schweiz Rundsch Med Prax; 1975 May; 64(19):595-8. PubMed ID: 51497
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical experience report on Hepavis].
    Menninger U; Menninger W
    Med Welt; 1980 Oct; 31(42):1519-21. PubMed ID: 7453534
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical study of citiolone, cyto-membranous hepatic protector].
    Varay A; Castel A; Bloch J
    Therapeutique; 1970 Dec; 46(10):993-5. PubMed ID: 5511936
    [No Abstract]   [Full Text] [Related]  

  • 20. [Observations on the treatment of chronic inflammatory liver diseases with the preparation Hepasteril B comp].
    Busse K; Otremba P
    Soins; 1970; 15(7):2608-13. PubMed ID: 4918343
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.